SecBot SecBot

KVUE

Kenvue Inc.
NYSE· Perfumes, Cosmetics & Other Toilet Preparations· Inc. DE· CIK 0001944048 Consumer & Retail
No price
Market cap
$37.6B
Large cap
Consensus
Hold
30% Buy or better · 20 analysts
Median target
$19.00
range $18.00–23.00
Short interest
52.38M
≈2.7% of shares · −6.0%
Days to cover
2.5
at average volume
Insider net
$0
no open-market trades · since Nov 2
New fund stakes
1
Q2 2026 13F · 2 exits
Filing reports
16
analyzed by SecBot
Congress trades
8
disclosed
SecBot read MIXED 9 reports · 90 days
Balance 0 bearish · 0 bullish · 3 mixed · 6 neutral oldest → newest, height = score
Avg score ·High conf. 7/9

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Nov 2. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 47 added (1 new), 33 trimmed or exited. Largest new: Voloridge Investment Management $10.7M.

  • AnalystsMIXED

    6 of 20 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −6.0% to 52.38M shares. 2.5 days to cover, ≈2.7% of shares.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 5.

Who's buying

13F· Q2 2026
1
new positions
2
exits
$10.7M
in new stakes
FundMoveSharesValue
JPMORGAN CHASE & CODOUBLED26,248,231$500.6M
AmundiADD18,483,326$353.2M
UBS Group AGTRIM13,556,452$259.1M
Swedbank ABADD9,400,874$179.7M
RENAISSANCE TECHNOLOGIES LLCDOUBLED9,024,812$172.5M
DEUTSCHE BANK AG\TRIM7,920,744$151.4M
D. E. Shaw & Co., Inc.TRIM7,616,358$145.5M
HSBC HOLDINGS PLCADD7,544,394$143.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

20 analysts
Hold 30% rate it Buy or better
Strong Buy2Buy4Hold14Sell0Strong Sell0
Recent actions
DateFirmActionRating
Nov 2, 2026UBS
MAINTAIN
MAINTAINNeutral
Aug 11, 2026UBS
MAINTAIN
MAINTAINNeutral
Jul 21, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Jul 16, 2026UBS
MAINTAIN
MAINTAINNeutral
Congressional trades
KVUE trades disclosed by members of Congress, with disclosure delay.
3 members · 2 buys / 6 sells
DateMemberType AmountDisclosed
Aug 5, 2026 Kevin HernRHouse Joint account · KENVUE INC SELL $1K–$15K Aug 10, 2026 +5d
Jul 17, 2026 Gilbert CisnerosDHouse KENVUE INC SELL $1K–$15K Sep 4, 2026 +49d
Jun 16, 2026 Gilbert CisnerosDHouse KENVUE INC BUY $1K–$15K Jul 2, 2026 +16d
May 15, 2026 Ro KhannaDHouse Spouse account · KENVUE INC SELL $1K–$15K Jun 9, 2026 +25d
Mar 17, 2026 Kevin HernRHouse Joint account · KENVUE INC SELL $15K–$50K Apr 3, 2026 +17d
Mar 13, 2026 Gilbert CisnerosDHouse KENVUE INC SELL $1K–$15K Apr 7, 2026 +25d
Feb 10, 2026 Gilbert CisnerosDHouse KENVUE INC BUY $1K–$15K Mar 9, 2026 +27d
Jan 9, 2026 Gilbert CisnerosDHouse KENVUE INC SELL $1K–$15K Feb 13, 2026 +35d

Insider ledger

Form 4
$0
open-market buys or sells · since Nov 2
DateInsiderTypeValue
Nov 2, 2026
Wondrasch Michael
Chief Tech & Data Officer
Nov 2, 2026
TO ISSUER215,876 sh
Nov 2, 2026
Wondrasch Michael
Chief Tech & Data Officer
Nov 2, 2026
TO ISSUER45,453 sh
Nov 2, 2026
Tillett Caroline
Chief Scientific Officer
Nov 2, 2026
TO ISSUER61,001.38 sh
Nov 2, 2026
Tillett Caroline
Chief Scientific Officer
Nov 2, 2026
AWARD61,001.38 sh
Nov 2, 2026
Tillett Caroline
Chief Scientific Officer
Nov 2, 2026
TO ISSUER12,230.75 sh
Nov 2, 2026
Tillett Caroline
Chief Scientific Officer
Nov 2, 2026
AWARD12,230.75 sh
Nov 2, 2026
Smith Jeffrey C
Director
Nov 2, 2026
TO ISSUER30,404.881 sh
Nov 2, 2026
Smith Jeffrey C
Director
Nov 2, 2026
TO ISSUER27,307,632 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$0.32$0.31–$0.33-2.2%$4.0B
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 2, 2026
Listing
Delisted: KVUE, removed from the N symbol directory
Kenvue Inc. Common Stock
Oct 30, 2026
Earnings result
KVUE Q3 2026 Earnings: EPS $0.29 (-3.5% vs est)
Oct 12, 2026
Enforcement
Commission approves Kimberly-Clark's acquisition of Kenvue, subject to conditions
European Commission Press release Brussels, 13 Oct 2026 The European Commission has approved, under the EU Merger Regulation, the proposed acquisition
Sep 28, 2026
Press release
Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes
DALLAS, Sept. 28, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the commencement, in connection…
Sep 15, 2026
Short interest
Short Interest: KVUE down 20% to 57.6M shares
Settlement 2026-09-15 | Days to cover: 1.73 | ≈3.00% of shares outstanding (est.)

Short side

FINRA· Oct 30, 2026
52,375,243
shares short
-6.0%
vs prior settlement
2.5
days to cover
≈2.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Kenvue Inc. filed Form 15-12G to terminate the registration of its common stock and suspend SEC reporting obligations…
15-12G · Impact 2/10
Nov 9, 2026 SEC
In Q3 2026, eight institutions added $52.9M to Kenvue positions while seven reduced holdings by $435.5M, a net selling…
INST-CLUSTER · Impact 3/10
Nov 5, 2026 SEC
Kenvue Inc.'s shelf registration statement (File No. 333-274376) became effective on November 4, 2026, under the…
EFFECT · Impact 3/10
Nov 2, 2026 Listing status
Delisted: KVUE, removed from the N symbol directory
Kenvue Inc. Common Stock
Nov 2, 2026 Insider
Wondrasch Michael disposed of 215,876 shares
Chief Tech & Data Officer
Nov 2, 2026 Insider
Wondrasch Michael disposed of 45,453 shares
Chief Tech & Data Officer
Nov 2, 2026 Insider
Tillett Caroline disposed of 61,001.38 shares
Chief Scientific Officer
Oct 12, 2026 Event
Commission approves Kimberly-Clark's acquisition of Kenvue, subject to conditions
European Commission Press release Brussels, 13 Oct 2026 The European Commission has approved, under
Reddit Mentions per day, 14 days
Recent posts
All social signals and their track records

Washington

Corporate Lobbying

26 lobbying filings and 8 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

16 filings · 2 bullish · 2 bearish · 4 mixed · 8 neutral
All KVUE filing & press-release reports (16)